Gp Act Iii Acquisition Stock Price To Sales
| GPAT Stock | 10.11 0.03 0.30% |
GP Act III Acquisition fundamentals help investors to digest information that contributes to GP Act's financial success or failures. It also enables traders to predict the movement of GPAT Stock. The fundamental analysis module provides a way to measure GP Act's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GP Act stock.
| Last Reported | Projected for Next Year |
GPAT |
GP Act III Acquisition Company Price To Sales Analysis
GP Act's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
GPAT Price To Sales Driver Correlations
Understanding the fundamental principles of building solid financial models for GP Act is extremely important. It helps to project a fair market value of GPAT Stock properly, considering its historical fundamentals such as Price To Sales. Since GP Act's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of GP Act's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of GP Act's interrelated accounts and indicators.
Click cells to compare fundamentals
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, GP Act III Acquisition has a Price To Sales of 0.0 times. This is 100.0% lower than that of the Financial Services sector and 100.0% lower than that of the Financials industry. The price to sales for all United States stocks is 100.0% higher than that of the company.
GPAT Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GP Act's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GP Act could also be used in its relative valuation, which is a method of valuing GP Act by comparing valuation metrics of similar companies.GP Act is currently under evaluation in price to sales category among its peers.
GPAT Fundamentals
| Current Valuation | 362.14 M | ||||
| Shares Outstanding | 28.75 M | ||||
| Shares Owned By Institutions | 40.32 % | ||||
| Number Of Shares Shorted | 3.41 K | ||||
| Price To Book | 1.30 X | ||||
| EBITDA | (14.04 K) | ||||
| Net Income | (14.04 K) | ||||
| Total Debt | 628.18 K | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (10.97 K) | ||||
| Short Ratio | 0.11 X | ||||
| Earnings Per Share | 0.15 X | ||||
| Market Capitalization | 362.25 M | ||||
| Total Asset | 530.24 K | ||||
| Retained Earnings | (122.94 K) | ||||
| Working Capital | (624.87 K) | ||||
| Net Asset | 530.24 K |
About GP Act Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GP Act III Acquisition's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GP Act using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GP Act III Acquisition based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for GPAT Stock Analysis
When running GP Act's price analysis, check to measure GP Act's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GP Act is operating at the current time. Most of GP Act's value examination focuses on studying past and present price action to predict the probability of GP Act's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GP Act's price. Additionally, you may evaluate how the addition of GP Act to your portfolios can decrease your overall portfolio volatility.